Drug
Zalfermin clinical trials
Also written NNC0194-0499.
- studies test it
- 9
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
9 studies that test it; most in 2023 (5)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 5 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
Often tested with
Tested in the same studies.
Semaglutide (2) · Cagrilintide (1) · Ethinyl Estradiol (1) · Levonorgestrel (1) · NC0194-0499 (1)
Studies
Open first, then newest update. How each study uses zalfermin is read from its arms, and is right about nine times in ten.
Testing it · 9
- Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver DiseaseCompletedPhase 2Novo Nordisk A/SNCT06409130Written as NNC0194-0499
- A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver FunctionCompletedPhase 1Novo Nordisk A/SNCT05917938Written as NNC0194-0499
- A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.CompletedPhase 1Novo Nordisk A/SNCT06188026Written as NNC0194-0499
- A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese MenCompletedPhase 1Novo Nordisk A/SNCT05742919Written as NNC0194-0499
- A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate FormulationsCompletedPhase 1Novo Nordisk A/SNCT05766709Written as NNC0194-0499
- A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney FunctionCompletedPhase 1Novo Nordisk A/SNCT05727644Written as NNC0194-0499
- A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian MenCompletedPhase 1Novo Nordisk A/SNCT04722653Written as NNC0194-0499
- A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or ObesityCompletedPhase 1Novo Nordisk A/SNCT03479892Written as NNC0194-0499
- First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or ObesityCompletedPhase 1Novo Nordisk A/SNCT03015207Written as NNC0194-0499
Given in every arm · 1 — zalfermin is usual care beside what is tested
Codes
What other systems call zalfermin · ClinicalTrials.gg INT019038
- UNII (FDA) EHX92ZUE0AZALFERMINOne source FDA
- NCI Thesaurus C203220ZalferminOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | EHX92ZUE0A | ZALFERMIN | One source FDA |
| NCI Thesaurus | C203220 | Zalfermin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.